Reply

Jan 17, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We read the letter from Dr Maloney with great interest and wholeheartedly agree that the off-label use of drugs and devices is appropriate in routine clinical practice. If he assumed…

read more

Off-Label Use of Drugs and Devices

Jan 17, 2017 by in OPHTHALMOLOGY Comments Off on Off-Label Use of Drugs and Devices

In their editorial “When is off-label drug use in the Patient’s Best Interest?,” Rosenfeld and Goodman raise ethical questions about the off-label use of intravitreal Infliximab to treat neovascular age-related…

read more

Two-Year Visual Results for Older Asian Women Treated With Photodynamic Therapy or Bevacizumab for Myopic Choroidal Neovascularization

Jan 17, 2017 by in OPHTHALMOLOGY Comments Off on Two-Year Visual Results for Older Asian Women Treated With Photodynamic Therapy or Bevacizumab for Myopic Choroidal Neovascularization

Purpose To compare the long-term visual and anatomic outcome of treatment with photodynamic therapy (PDT) or intravitreal bevacizumab (IVB; Avastin; Genentech Inc, South San Francisco, California, USA) for choroidal neovascularization…

read more

Subthreshold Micropulse Diode Laser Photocoagulation for Diabetic Macular Edema in Japanese Patients

Jan 17, 2017 by in OPHTHALMOLOGY Comments Off on Subthreshold Micropulse Diode Laser Photocoagulation for Diabetic Macular Edema in Japanese Patients

Purpose To assess the efficacy and safety of subthreshold micropulse diode laser photocoagulation for diabetic macular edema (ME). Design Prospective, nonrandomized interventional case series. Methods setting: Institutional. patients: Thirty-six consecutive…

read more
Get Clinical Tree app for offline access